Results 251 to 260 of about 25,508,313 (370)

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Cancer as a System Failure

Cancer Informatics, 2007
Igor Jurisica, Dennis Wigle
doaj  

Modeling the therapeutic dynamics of acupuncture and moxibustion: a systems biology approach to treatment optimization. [PDF]

Comput Struct Biotechnol J
Gan Q, Ge QW, Liu C, Zhong Z, Wu J, Shi L, Xu J, Li C.   +7 more
europepmc   +1 more source

On the wings of checkerspots: a model system for population biology [PDF]

, 2004
Paul R. Ehrlich, Ilkka Hanski
openalex   +1 more source

Systems biology guided by XCMS Online metabolomics

Nature Methods, 2017
T. Huan, E. Forsberg, Duane Rinehart, Caroline H. Johnson, Caroline H. Johnson, J. Ivanisevic, H. P. Benton, Mingliang Fang, Mingliang Fang, A. Aisporna, Brian Hilmers, F. Poole, M. Thorgersen, M. Adams, Gregory P. Krantz, M. Fields, P. Robbins, L. Niedernhofer, T. Ideker, E. L. Majumder, J. Wall, N. Rattray, N. Rattray, R. Goodacre, L. Lairson, G. Siuzdak   +25 more
semanticscholar   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

From Parts to Whole: A Systems Biology Approach to Decoding Milk Fever. [PDF]

Vet Sci
Ametaj BN.
europepmc   +1 more source

Biology of the gonadotropin-releasing hormone system in gynecological cancers

, 2002
Carsten Gründker, AR Gunthert, S Westphalen, Günter Emons   +3 more
openalex   +1 more source

Systems Biology: The Big Picture [PDF]

, 2004
Angela Spivey
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source